Cummings, Jeffrey http://orcid.org/0000-0001-8944-4158
Osse, Amanda M. Leisgang
Cammann, Davis
Powell, Jayde
Chen, Jingchun
Funding for this research was provided by:
National Institute of General Medical Sciences (P20GM109025)
National Institute of Neurological Disorders and Stroke (U01NS093334)
National Institute on Aging (R01AG053798, P20AG068053, P30AG072959, R35AG71476)
Alzheimer's Drug Discovery Foundation
Ted and Maria Quirk Endowment
Joy Chambers-Grundy Endowment
Article History
Accepted: 11 October 2023
First Online: 13 November 2023
Declarations
:
: Jeffrey Cummings has provided consultation to Acadia, Actinogen, Acumen, AlphaCognition, Aprinoia, AriBio, Artery, Biogen, BioVie, Cassava, Cerecin, Diadem, EIP Pharma, Eisai, GemVax, Genentech, GAP Innovations, Janssen, Jocasta, Karuna, Lilly, Lundbeck, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Optoceutics, Ono, Otsuka, PRODEO, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, Suven, SynapseBio, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Davis Cammann, Jayde Powell, Amanda Leisgang Osse, and Jingchun Chen have no disclosures to declare in relation to this work.
: No funding was received specifically for the development of this manuscript. Production of the manuscript is consistent with the lead author’s R35 award from the National Institute on Aging (NIA grant R35AG71476).
: No patient data are included in this article and all information is publicly available. No ethics approval is required.
: No patients were included this this article. All information is available on ClinicalTrials.gov or derived from PubMed sources. No patient consent is required.
: No database was developed for this article. All material cited is available on PubMed and cited in the references or derived from the publicly available registry ClinicalTrials.gov.
: No database was developed for this article. All material cited is available on PubMed and cited in the references or derived from the publicly available registry ClinicalTrials.gov.
: All authors contributed to this article and approved the final manuscript. Each of the authors developed the section on at least one monoclonal antibody. Jeffrey Cummings conceived the article and produced the original outline. The outline was approved by all authors. Amanda Leisgang Osse managed the references and Mike de la Flor created the illustration.